TickrTrends LQDA fair value analysis

Liquidia soars 27% after settlement resolves litigation (LQDA:NASDAQ)

seekingalpha.com · 2026-10-14

Liquidia (LQDA) surges after settling United Therapeutics litigation, lifting uncertainty around YUTREPIA.

Read the full story at seekingalpha.com →

Is LQDA undervalued? See TickrTrends' fair value analysis →